drugset
drugset / Trial / NCT07059832

Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors

NCT07059832 ↗

Phase 1/2 Active not recruiting 30 enrolled First Hospital of China Medical University
NaSingle-groupOpen-labelDiagnostic

Summary

This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the safety and clinical predictive value of 68Ga-NODAGA-SNA006 in subjects with solid tumor or lymphoma.

Timeline

Start
2024-04-01
Primary completion
2028-01-01
Completion
2028-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-NODAGA-SNA006 Protein / enzyme biologic 1.85 mbq/kg Intravenous

Indications

cancer